“The top United Nations relief official said [.pdf] today that humanitarian efforts to alleviate the devastating food crisis affecting Mali have begun to yield results, but warned that much still remains to be done and the situation could worsen without continued donor support,” the U.N. News Centre reports (8/30). Under-Secretary-General for Humanitarian Affairs Valerie Amos “on Thursday called for more resources in Mali to save children from severe malnutrition,” Agence France-Presse reports. The widespread food crisis in the Sahel region is compounded in Mali by a militant insurgency in the north of the country, according to the news agency. “The food crisis, which follows a drought in 2011, has affected 4.6 million people in Mali alone,” and “[a]lmost 150,000 children across Mali have been treated for acute malnutrition … this year,” the news agency writes (8/30).
Programs, Funding & Financing
U.S. Ambassador to Nigeria Terence McCulley spoke on Monday in Abuja at the inauguration of a Defense Reference Laboratory, Leadership reports, noting he said the laboratory, “which is the first of its kind in the sub-region,” was supported by U.S. funding. According to the newspaper, McCulley said the Reference Laboratory Program is part of U.S. assistance to Nigeria through a partnership between the U.S. Department of Defense (DOD) and Nigeria’s Ministry of Defense (NMOD) through the Walter Reed Program (WRP-N) and the Emergency Plan Implementation Committee (EPIC), which began in 2005 (8/30).
As the BRIC countries — Brazil, Russia, India, and China — invest more in innovations in health technologies and other areas, “many are looking to these countries to correct the global health research and development (R&D) imbalance that leaves the poor without needed products such as an improved tuberculosis (TB) vaccine or tests to help diagnose patients in remote rural settings,” David de Ferranti, president of Results for Development Institute (R4D), writes in the Huffington Post Blog. Writing that “India, which has already played such an important role in manufacturing affordable antiretroviral drugs, vaccines, and other essential health commodities for developing countries,” de Ferranti asks whether India “is … ready to play a leading role in health R&D?”
Peruvian President Ollanta Humala on Monday said the country’s central government and regional governments would provide $1.03 million to a fund aimed at reducing child malnutrition, Andean Air Mail & Peruvian Times reports. “Humala said the government aims to lower the [child malnutrition] rate to 10 percent by 2016, from 23 percent in 2010,” according to the news service (8/28). “These funds, he said, will be used for the comprehensive care of children and pregnant or breastfeeding women, the provision of vaccines, social programs, among others,” Bernama/NNN/Andina write. According to the news services, “The announcement was made during the signing of the National Commitment to the Coordinated Fight Against Child Malnutrition, which Humala described as a ‘concrete measure which must bring together all regional governments.'” He said, “What we want to do is eradicate malnutrition. As a government, we are going to fight as hard as we can to eradicate it,” the news services report (8/29).
“The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria has approved 45 new two-year grants, from 37 countries, totaling $419.2 million, to fund essential prevention, treatment, and care services provided to the people affected by the three diseases,” according to a Global Fund press release. “Another 11 proposals worth a total of $91.2 million were sent back for revision, and are subject to a further independent technical review before they can be approved,” the press release adds, noting the grant approvals are part of the Transitional Funding Mechanism and “will bridge the financing of essential interventions until the next opportunity to apply for grants” (8/28). According to the U.N. News Centre, the Global Fund “has approved funding of $22.9 billion for more than 1,000 programs in 151 countries, and helped programs provide AIDS treatment for 3.6 million people, anti-tuberculosis treatment for 9.3 million people, and 270 million insecticide-treated nets for the prevention of malaria” (8/28).
UNICEF Official Calls For Increased Investment In Child Mortality To Achieve MDGs; New U.N. Estimates Due Next Month
Mickey Chopra, chief health officer at UNICEF, has called for increased investment in reducing child mortality, the Guardian reports, writing Chopra “said investment now would lead to massive strides in meeting the Millennium Development Goals [MDGs] of reducing maternal deaths by three-quarters (MDG4) and the deaths of children under five by two-thirds (MDG5), both by 2015.” The newspaper adds, “Since 1990, annual maternal deaths have declined by almost half and the deaths of young children have fallen from 12 million to 7.6 million in 2010,” but “many countries — especially in Africa and south Asia — are not making progress” (Tran, 8/28) “Given current trends, the child mortality goal set out by U.N. officials won’t be reached until 2038,” according to U.N. researchers, LiveScience notes.
“According to analysis led by Kanika Bahl and Pooja Shaw of Results for Development’s (R4D’s) Market Dynamics team, improved global incentives and information on cost-effectiveness could save the fight against malaria up to $630 million over the next five years and encourage manufacturers to produce better-performing nets,” Bahl, a managing director for R4D, and Shaw, a program officer in the Market Dynamics Practice at R4D, write in the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog. “Using their central position in global [long-lasting insecticide-treated net (LLIN)] markets, donor institutions can introduce policy incentives to focus on cost-effectiveness and rationalize specifications so that suppliers can take advantage of economies of scale in production,” they continue, adding, “To implement these policies, global guidance on the performance of various nets is urgently needed, and this is where organizations such as the WHO can provide direction” (8/27).
Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Monday published Issue 193 of its “Global Fund Observer.” The issue features an article announcing the Global Fund’s Transitional Funding Mechanism (TFM) decisions; an article reporting the results of the TFM decisions by country; and an article about a new report from the Global Fund Board on challenges in grant implementation, among others (8/27).
In this post in the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog, Bill Gates, co-chair of the foundation, reflects on Angola’s success against polio, writing, “Angola marked a full year without a new case of polio” this month, an accomplishment that serves as “the latest evidence that we are extremely close to ending polio forever.” He continues, “Polio is a formidable foe and Angola is one of the world’s poorest nations with numerous health challenges to tackle, which makes Angola’s achievement especially noteworthy,” adding, “Like all 125 countries that have gotten rid of polio since 1988, Angola’s leaders and citizens also deserve the global resolve needed to ensure that no country ever has to go back and re-do the hard, expensive work that’s already been done to protect their children from polio” (8/27).
Small, Ingestible Sensor Can Track Patient Medication Intake, Activity Levels; Technology To Be Tested For TB Treatment
The FDA last month approved for use a small ingestible sensor that, when embedded into a pill, can help “keep track of whether a patient is taking their medicine on time,” Reuters reports. “The digital feedback technology, devised by Redwood City, California-based Proteus Digital Health Inc., can also prompt patients to take their medicine and even ask them to take a walk if they have been inactive for too long,” the news service writes. “Proteus has a partnership with the Bill & Melinda Gates Foundation and China’s Center for Disease Control and Prevention to test the technology in tuberculosis treatment,” Reuters notes, adding, “Pills for anything from the common cold to diabetes or cancer can be embedded.”